SEC Form D · Amendment · filed October 15, 2014
Immunomic Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (19)
James D. Wishart · Lexington Park, MDExec · DirectorBruce F. Mackler · Rockville, MDExec · DirectorTeri J. Heiland · Lancaster, PAExecMichael D. Lack · Lancaster, PADirectorWilliam G. Hearl · Lancaster, PAExec · Director · PromoterBernard C. Rudnick · Lancaster, PAExec · DirectorRonald D. Thiboutot · Harrisburg, PADirectorWilliam B. Mcdonald · Monarch Beach, CADirectorMichael Solomon · New York, NYExecTodd Carter · New York, NYExec · DirectorAnthony J. De Laurentis · Baltimore, MDDirectorNathanael Clemensen · PALO ALTO, CADirectorColeman Andrews · PALO ALTO, CAExec · DirectorRmwc Credit Alpha Fund GP, LLC · PALO ALTO, CAExec · Director · PromoterRachel Markus · PALO ALTO, CADirectorMichael Rubenstein · PALO ALTO, CAExec · DirectorLaurence Wainer · Beverly Hills, CAExec · Director · PromoterGreg Schmergel · Woburn, MADirectorDave Fachetti · Woburn, MAExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗